Artificial Intelligence (AI) in Pharmaceutical Market, By Offering (Hardware, Software, Services), Application (Drug Discovery, Precision Medicine, Medical Imaging & Diagnostics, Research), Deployment, Technology, Region - Global Forecast to 2028
The Artificial Intelligence (AI) in Pharmaceutical Market size is estimated to grow from USD XX Billion in 2021 to USD XX Billion by 2028, growing at a CAGR of XX% during the forecast year from 2021 to 2028.
The latest report on Artificial Intelligence (AI) in Pharmaceutical Market understands market size estimates, forecasts, market shares, competition analysis, along with industry trends of Artificial Intelligence (AI) in Pharmaceutical with emphasis on market timelines and technology roadmaps analysis.
The Artificial Intelligence (AI) in Pharmaceutical market is segmented by Offering, Application, Deployment, Technology, Region. The research covers the current and historic Artificial Intelligence (AI) in Pharmaceutical market size and its growth trend with company outline of key players: GNS Healthcare, IBM Watson, Merck & Co., Microsoft Corporation, Novartis AG, AstraZeneca LLC, Atomwise Inc., Bayer AG, Cloud Pharmaceuticals Inc, NVIDIA Corporation, Pfizer Inc., Recursion Pharmaceuticals Inc., and XtalPi Inc.
Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as product launches and acquisitions.
The objective of this study is to identify the market opportunities and estimate market size by segments and countries for last few years and to forecast the values to the next five years. The report incorporates both the qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. The report also covers qualitative analysis on the market, by incorporating complete pricing and cost analysis of components & products, Porter’s analysis and PEST (Political, Economic, Social & Technological factor) analysis of the market. The report also profiles all major companies active in this field.
Market Analysis and Insights: Artificial Intelligence (AI) in Pharmaceutical Market Analysis & Insights
Artificial Intelligence (AI) in Pharmaceutical Market Scope and Market Size
Artificial Intelligence (AI) in Pharmaceutical market is segmented by Offering, Application, Deployment, Technology, Region. Players, stakeholders, and other participants in the global Artificial Intelligence (AI) in Pharmaceutical market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue and forecast for the period 2022-2028.
Report further studies the market development status and future and Artificial Intelligence (AI) in Pharmaceutical Market trend across the world. Also, it splits Artificial Intelligence (AI) in Pharmaceutical market segmentation by Offering, Application, Deployment, Technology, Region to deep dive research and reveals market profile and prospects.
Artificial Intelligence (AI) in Pharmaceutical Market Segments Covered in the Report
By Offering:
Hardware
Software
Services
By Application:
Drug Discovery
Precision Medicine
Medical Imaging & Diagnostics
Research
By Deployment:
Cloud
On-Premise
By Technology:
Machine Learning
Natural Language Processing
Deep Learning
Others
By Region
North America
US
Canada
Europe
UK
Germany
Franc
Rest of Europe
Asia-Pacific (APAC)
China
Japan
India
Rest of APAC
Rest of the World (RoW)
Middle East
Africa
South America
Reason to purchase this Artificial Intelligence (AI) in Pharmaceutical Market Report:
Determine prospective investment areas based on a detailed trend analysis of the global Artificial Intelligence (AI) in Pharmaceutical Market over the next years.
Gain an in-depth understanding of the underlying factors driving demand for different and Artificial Intelligence (AI) in Pharmaceutical market segments in the top spending countries across the world and identify the opportunities offered by each of them.
Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
Identify the major channels that are driving the global Artificial Intelligence (AI) in Pharmaceutical market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global Artificial Intelligence (AI) in Pharmaceutical market.
Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top Artificial Intelligence (AI) in Pharmaceutical market providers around the world which include information about their products, alliances, recent contract wins and financial analysis wherever available.
The latest report on Artificial Intelligence (AI) in Pharmaceutical Market understands market size estimates, forecasts, market shares, competition analysis, along with industry trends of Artificial Intelligence (AI) in Pharmaceutical with emphasis on market timelines and technology roadmaps analysis.
The Artificial Intelligence (AI) in Pharmaceutical market is segmented by Offering, Application, Deployment, Technology, Region. The research covers the current and historic Artificial Intelligence (AI) in Pharmaceutical market size and its growth trend with company outline of key players: GNS Healthcare, IBM Watson, Merck & Co., Microsoft Corporation, Novartis AG, AstraZeneca LLC, Atomwise Inc., Bayer AG, Cloud Pharmaceuticals Inc, NVIDIA Corporation, Pfizer Inc., Recursion Pharmaceuticals Inc., and XtalPi Inc.
Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as product launches and acquisitions.
The objective of this study is to identify the market opportunities and estimate market size by segments and countries for last few years and to forecast the values to the next five years. The report incorporates both the qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. The report also covers qualitative analysis on the market, by incorporating complete pricing and cost analysis of components & products, Porter’s analysis and PEST (Political, Economic, Social & Technological factor) analysis of the market. The report also profiles all major companies active in this field.
Market Analysis and Insights: Artificial Intelligence (AI) in Pharmaceutical Market Analysis & Insights
Artificial Intelligence (AI) in Pharmaceutical Market Scope and Market Size
Artificial Intelligence (AI) in Pharmaceutical market is segmented by Offering, Application, Deployment, Technology, Region. Players, stakeholders, and other participants in the global Artificial Intelligence (AI) in Pharmaceutical market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue and forecast for the period 2022-2028.
Report further studies the market development status and future and Artificial Intelligence (AI) in Pharmaceutical Market trend across the world. Also, it splits Artificial Intelligence (AI) in Pharmaceutical market segmentation by Offering, Application, Deployment, Technology, Region to deep dive research and reveals market profile and prospects.
Artificial Intelligence (AI) in Pharmaceutical Market Segments Covered in the Report
By Offering:
Hardware
Software
Services
By Application:
Drug Discovery
Precision Medicine
Medical Imaging & Diagnostics
Research
By Deployment:
Cloud
On-Premise
By Technology:
Machine Learning
Natural Language Processing
Deep Learning
Others
By Region
North America
US
Canada
Europe
UK
Germany
Franc
Rest of Europe
Asia-Pacific (APAC)
China
Japan
India
Rest of APAC
Rest of the World (RoW)
Middle East
Africa
South America
Reason to purchase this Artificial Intelligence (AI) in Pharmaceutical Market Report:
Determine prospective investment areas based on a detailed trend analysis of the global Artificial Intelligence (AI) in Pharmaceutical Market over the next years.
Gain an in-depth understanding of the underlying factors driving demand for different and Artificial Intelligence (AI) in Pharmaceutical market segments in the top spending countries across the world and identify the opportunities offered by each of them.
Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
Identify the major channels that are driving the global Artificial Intelligence (AI) in Pharmaceutical market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global Artificial Intelligence (AI) in Pharmaceutical market.
Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top Artificial Intelligence (AI) in Pharmaceutical market providers around the world which include information about their products, alliances, recent contract wins and financial analysis wherever available.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1. Key Takeaways
2.2. Report Description
2.3. Market Scope & Definition
2.4. Stakeholders
2.5. Research Methodology
2.5.1. Market Size
2.5.2. Key Data Points From Primary Sources
2.5.3. Key Data Points From Secondary Sources
2.5.4. List Of Primary Sources
2.5.5. List Of Secondary Sources
3. MARKET OVERVIEW
3.1. Industry Segmentation
3.2. Market Trends Analysis
3.3. Major Funding & Investments
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Value Chain Analysis
3.6. Pricing Analysis
4. IMPACT OF COVID-19 ON ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET
4.1. Impact Of Covid-19 On Market, By Offering
4.2. Impact Of Covid-19 On Market, By Application
4.3. Impact Of Covid-19 On Market, By Deployment
4.4. Impact Of Covid-19 On Market, By Technology
4.5. Impact of Covid-19 On Market, By Region
5. ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET, BY OFFERING
5.1. Introduction
5.2. Hardware
5.3. Software
5.4. Services
6. ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET, BY APPLICATION
6.1. Introduction
6.2. Drug Discovery
6.3. Precision Medicine
6.4. Medical Imaging & Diagnostics
6.5. Research
7. ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET, BY DEPLOYMENT
7.1. Introduction
7.2. Cloud
7.3. On-Premise
8. ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET, BY TECHNOLOGY
8.1. Introduction
8.2. Machine Learning
8.3. Natural Language Processing
8.4. Deep Learning
8.5. Others
9. ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET, BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Rest of Europe
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest Of Asia Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. COMPETITIVE ANALYSIS
10.1. Introduction
10.2. Top Companies Ranking
10.3. Market Share Analysis
10.4. Recent Developments
10.4.1. New Product Launch
10.4.2. Mergers & Acquisitions
10.4.3. Collaborations, Partnerships & Agreements
10.4.4. Rewards & Recognition
11. COMPANY PROFILES
11.1. GNS Healthcare
11.2. IBM Watson
11.3. Merck & Co.
11.4. Microsoft Corporation
11.5. Novartis AG
11.6. AstraZeneca LLC
11.7. Atomwise Inc.
11.8. Bayer AG
11.9. Cloud Pharmaceuticals Inc
11.10. NVIDIA Corporation
11.11. Pfizer Inc.
11.12. Recursion Pharmaceuticals Inc.
11.13. and XtalPi Inc
2. INTRODUCTION
2.1. Key Takeaways
2.2. Report Description
2.3. Market Scope & Definition
2.4. Stakeholders
2.5. Research Methodology
2.5.1. Market Size
2.5.2. Key Data Points From Primary Sources
2.5.3. Key Data Points From Secondary Sources
2.5.4. List Of Primary Sources
2.5.5. List Of Secondary Sources
3. MARKET OVERVIEW
3.1. Industry Segmentation
3.2. Market Trends Analysis
3.3. Major Funding & Investments
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. Value Chain Analysis
3.6. Pricing Analysis
4. IMPACT OF COVID-19 ON ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET
4.1. Impact Of Covid-19 On Market, By Offering
4.2. Impact Of Covid-19 On Market, By Application
4.3. Impact Of Covid-19 On Market, By Deployment
4.4. Impact Of Covid-19 On Market, By Technology
4.5. Impact of Covid-19 On Market, By Region
5. ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET, BY OFFERING
5.1. Introduction
5.2. Hardware
5.3. Software
5.4. Services
6. ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET, BY APPLICATION
6.1. Introduction
6.2. Drug Discovery
6.3. Precision Medicine
6.4. Medical Imaging & Diagnostics
6.5. Research
7. ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET, BY DEPLOYMENT
7.1. Introduction
7.2. Cloud
7.3. On-Premise
8. ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET, BY TECHNOLOGY
8.1. Introduction
8.2. Machine Learning
8.3. Natural Language Processing
8.4. Deep Learning
8.5. Others
9. ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET, BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Rest of Europe
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest Of Asia Pacific
9.5. Rest of the World
9.5.1. Middle East
9.5.2. Africa
9.5.3. Latin America
10. COMPETITIVE ANALYSIS
10.1. Introduction
10.2. Top Companies Ranking
10.3. Market Share Analysis
10.4. Recent Developments
10.4.1. New Product Launch
10.4.2. Mergers & Acquisitions
10.4.3. Collaborations, Partnerships & Agreements
10.4.4. Rewards & Recognition
11. COMPANY PROFILES
11.1. GNS Healthcare
11.2. IBM Watson
11.3. Merck & Co.
11.4. Microsoft Corporation
11.5. Novartis AG
11.6. AstraZeneca LLC
11.7. Atomwise Inc.
11.8. Bayer AG
11.9. Cloud Pharmaceuticals Inc
11.10. NVIDIA Corporation
11.11. Pfizer Inc.
11.12. Recursion Pharmaceuticals Inc.
11.13. and XtalPi Inc
